The latest closing stock price for Xeris Biopharma Holdings as of November 08, 2024 is 3.47.
An investor who bought $1,000 worth of Xeris Biopharma Holdings stock at the IPO in 2018 would have $-828 today, roughly -1 times their original investment - a -25.45% compound annual growth rate over 6 years.
The all-time high Xeris Biopharma Holdings stock closing price was 27.23 on September 10, 2018.
The Xeris Biopharma Holdings 52-week high stock price is 3.64, which is 4.9% above the current share price.
The Xeris Biopharma Holdings 52-week low stock price is 1.46, which is 57.9% below the current share price.
The average Xeris Biopharma Holdings stock price for the last 52 weeks is 2.41.
An investor who bought $1,000 worth of Xeris Biopharma Holdings stock at the IPO in 2018 would have $-828 today, roughly -1 times their original investment - a -25.45% compound annual growth rate over 6 years.
The all-time high Xeris Biopharma Holdings stock closing price was 27.23 on September 10, 2018.
The Xeris Biopharma Holdings 52-week high stock price is 3.64, which is 4.9% above the current share price.
The Xeris Biopharma Holdings 52-week low stock price is 1.46, which is 57.9% below the current share price.
The average Xeris Biopharma Holdings stock price for the last 52 weeks is 2.41.